BioDelivery Sciences International Inc
NASDAQ:BDSI
BioDelivery Sciences International Inc
Gross Profit
BioDelivery Sciences International Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioDelivery Sciences International Inc
NASDAQ:BDSI
|
Gross Profit
$143.3m
|
CAGR 3-Years
53%
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Gross Profit
$59.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Gross Profit
$34.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Gross Profit
$38.8B
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
Merck & Co Inc
NYSE:MRK
|
Gross Profit
$46B
|
CAGR 3-Years
17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
Eli Lilly and Co
NYSE:LLY
|
Gross Profit
$28.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
See Also
What is BioDelivery Sciences International Inc's Gross Profit?
Gross Profit
143.3m
USD
Based on the financial report for Dec 31, 2021, BioDelivery Sciences International Inc's Gross Profit amounts to 143.3m USD.
What is BioDelivery Sciences International Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
102%
Over the last year, the Gross Profit growth was 9%. The average annual Gross Profit growth rates for BioDelivery Sciences International Inc have been 53% over the past three years , 102% over the past five years .